ANTI-TENASCIN-C (TNC) SINGLE-DOMAIN ANTIBODIES (NANOBODIES) AND USE THEREOF Application WO-2022175486-A1 World Intellectual Property Organisation (WIPO) 25 Aug 2022
ANTI-TENASCIN-C (TNC) SINGLE-DOMAIN ANTIBODIES (NANOBODIES) AND USE THEREOF Application EP-4047016-A1 European Patent Office 24 Aug 2022
Anti-ED-A immunoconjugates for inflammatory bowel disease Grant US-10239939-B2 United States of America 26 Mar 2019
Antigen associated with lung cancers and lymphomas Grant US-10202442-B2 United States of America 12 Feb 2019